Results 171 to 180 of about 63,852 (318)

Rethinking natriuretic peptides: hypoxia and haemoconcentration in atrial fibrillation. [PDF]

Heart
Arjamaa O.
europepmc   +1 more source

Cellular mechanisms of the clearance function of type C receptors of atrial natriuretic factor.

, 1990
Daniel R. Nussenzveig, John Lewicki, Thomas Maack   +2 more
openalex   +1 more source

Atrial natriuretic factor in cirrhosis with ascites: Plasma levels, cardiac release and splanchnic extraction [PDF]

, 1988
Pere Ginès, Wladimiro Jiménez, Vicente Arroyo, Miquel Navasa, Clara López, Lluçia Titó, Antoni Serra, Jaime Bosch, G Sánz, Francisca Rivera, Joan Rodés   +10 more
openalex   +1 more source

Tumor Necrosis Factor Superfamily 14: A Potential Predictor of Atrial Fibrillation Recurrence After Catheter Ablation. [PDF]

Clin Cardiol
Zhou D, Liu F, Liu T, Li M, Jiang C, Tang R, Wang W, Zhao X, Li C, Jia C, Ning M, Feng L, Wen D, Lin J, Zhu H, Jiang Y, Guo X, Li S, Jiang C, Zhou N, Sang C, Long D, Du X, Dong J, Ma C.   +24 more
europepmc   +1 more source

Friend of GATA 2 Physically Interacts with Chicken Ovalbumin Upstream Promoter-TF2 (COUP-TF2) and COUP-TF3 and Represses COUP-TF2-dependent Activation of the Atrial Natriuretic Factor Promoter [PDF]

, 2001
Gordon S. Huggins, Christopher J. Bacani, Jay Boltax, Ryuichi Aikawa, Jeffrey M. Leiden   +4 more
openalex   +1 more source

Pre‐anaesthetic risk assessment and management of dogs with myxomatous mitral valve disease: a spectrum of care narrative review

Journal of Small Animal Practice, EarlyView.
Myxomatous mitral valve disease, an acquired valvular degeneration, is the most common cardiac disorder in dogs, affecting approximately 10% of dogs in primary care veterinary practice. Dogs with myxomatous mitral valve disease frequently require anaesthesia for routine procedures.
I. Levinzon, L. Köster, E. Vettorato, A. H. Estrada   +3 more
wiley   +1 more source

Strengths and limitations of HFpEF probability scores in the era of precision medicine. [PDF]

Front Med (Lausanne)
Wilk M, Kotwica T, Zymliński R, Gajewski P.   +3 more
europepmc   +1 more source

Ganglionic immunoreactive atrial natriuretic factor in rat experimental hypertension. [PDF]

, 1988
Otto Kuchel, Waldemar Debinski, Nguyen T. Buu, M. Cantin, Jacques Genest   +4 more
openalex   +1 more source

Night‐To‐Night Variability in Sleep Apnea Is Associated With Persistence and Burden of Device‐Detected Atrial Fibrillation

Journal of Sleep Research, EarlyView.
Device detected atrial fibrillation and sleep apnea. CV = coefficient of variation; RDI = Respiratory disturbance index. ABSTRACT Using pacemaker‐derived thoracic impedance monitoring, sleep apnea severity and its night‐to‐night variability can be continuously tracked in patients with implanted cardiac devices.
Philipp Spitaler, Valentin Bilgeri, Patrick Rockenschaub, Fabian Barbieri, Birkan Tugrul, Agne Adukauskaite, Markus Stühlinger, Bernhard Erich Pfeifer, Peter Willeit, Axel Bauer, Wolfgang Dichtl   +10 more
wiley   +1 more source

Atrial Cardiomyopathy and Atrial Fibrillation in Different Heart Failure Substrates. [PDF]

Arrhythm Electrophysiol Rev
Kantharia BK, Wu L, Hulsurkar MM, Karimzad K, Shah AN, Narasimhan B, Wehrens XH, Linz D, Heijman J.   +8 more
europepmc   +1 more source